Literature DB >> 22754588

Risk Factors of Follicular Lymphoma.

Shuangge Ma1.   

Abstract

INTRODUCTION: Non-Hodgkin Lymphoma (NHL) is a heterogeneous group of malignancies with over thirty different subtypes. Follicular lymphoma (FL) is the most common form of indolent NHL and the second most common form of NHL overall. It has morphologic, immunophenotypic and clinical features significantly different from other subtypes. Considerable effort has been devoted to the identification of risk factors for etiology and prognosis of FL. These risk factors may advance our understanding of the biology of FL and have an impact on clinical practice. AREAS COVERED: The epidemiology of NHL and FL is briefly reviewed. For FL etiology and prognosis separately, we review clinical, environmental and molecular (including genetic, genomic, epigenetic and others) risk factors suggested in the literature. EXPERT OPINION: A large number of potential risk factors have been suggested in recent studies. However, there is a lack of consensus, and many of the suggested risk factors have not been rigorously validated in independent studies. There is a need for large-scale, prospective studies to consolidate existing findings and discover new risk factors. Some of the identified risk factors are successful at the population level. More effective individual-level risk factors and models remain to be identified.

Entities:  

Year:  2012        PMID: 22754588      PMCID: PMC3384553          DOI: 10.1517/17530059.2012.686996

Source DB:  PubMed          Journal:  Expert Opin Med Diagn        ISSN: 1753-0059


  66 in total

1.  Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph).

Authors:  Sophia S Wang; Susan L Slager; Paul Brennan; Elizabeth A Holly; Silvia De Sanjose; Leslie Bernstein; Paolo Boffetta; James R Cerhan; Marc Maynadie; John J Spinelli; Brian C H Chiu; Pier Luigi Cocco; Fiona Mensah; Yawei Zhang; Alexandra Nieters; Luigino Dal Maso; Paige M Bracci; Adele Seniori Costantini; Paolo Vineis; Richard K Severson; Eve Roman; Wendy Cozen; Dennis Weisenburger; Scott Davis; Silvia Franceschi; Carlo La Vecchia; Lenka Foretova; Nikolaus Becker; Anthony Staines; Martine Vornanen; Tongzhang Zheng; Patricia Hartge
Journal:  Blood       Date:  2006-12-21       Impact factor: 22.113

2.  Gene expression profiling of follicular lymphoma and normal germinal center B cells using cDNA arrays.

Authors:  Hervé Husson; Elizabeth G Carideo; Donna Neuberg; Joachim Schultze; Olivier Munoz; Peter W Marks; John W Donovan; Antoinette C Chillemi; Peter O'Connell; Arnold S Freedman
Journal:  Blood       Date:  2002-01-01       Impact factor: 22.113

3.  Smoking, alcohol use, obesity, and overall survival from non-Hodgkin lymphoma: a population-based study.

Authors:  Susan M Geyer; Lindsay M Morton; Thomas M Habermann; Cristine Allmer; Scott Davis; Wendy Cozen; Richard K Severson; Charles F Lynch; Sophia S Wang; Matthew J Maurer; Patricia Hartge; James R Cerhan
Journal:  Cancer       Date:  2010-06-15       Impact factor: 6.860

4.  Body mass index and risk of malignant lymphoma in Scandinavian men and women.

Authors:  Ellen T Chang; Henrik Hjalgrim; Karin Ekström Smedby; Måns Akerman; Edneia Tani; Hans E Johnsen; Bengt Glimelius; Hans-Olov Adami; Mads Melbye
Journal:  J Natl Cancer Inst       Date:  2005-02-02       Impact factor: 13.506

5.  p16(INK4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin's lymphomas.

Authors:  M Pinyol; F Cobo; S Bea; P Jares; I Nayach; P L Fernandez; E Montserrat; A Cardesa; E Campo
Journal:  Blood       Date:  1998-04-15       Impact factor: 22.113

Review 6.  Follicular lymphoma prognostic factors in the modern era: what is clinically meaningful?

Authors:  Ph Solal-Céligny; X Cahu; G Cartron
Journal:  Int J Hematol       Date:  2010-08-31       Impact factor: 2.490

7.  Gene expression profile of serial samples of transformed B-cell lymphomas.

Authors:  Sven de Vos; Wolf-Karsten Hofmann; Thomas M Grogan; Utz Krug; Mathew Schrage; Thomas P Miller; Jonathan G Braun; William Wachsman; H Phillip Koeffler; Jonathan W Said
Journal:  Lab Invest       Date:  2003-02       Impact factor: 5.662

8.  Aberrant DNA methylation of p57(KIP2) gene in the promoter region in lymphoid malignancies of B-cell phenotype.

Authors:  Yinghua Li; Hirokazu Nagai; Toshihito Ohno; Masaaki Yuge; Sonoko Hatano; Etsuro Ito; Naoyoshi Mori; Hidehiko Saito; Tomohiro Kinoshita
Journal:  Blood       Date:  2002-10-01       Impact factor: 22.113

9.  Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32.

Authors:  Lucia Conde; Eran Halperin; Nicholas K Akers; Kevin M Brown; Karin E Smedby; Nathaniel Rothman; Alexandra Nieters; Susan L Slager; Angela Brooks-Wilson; Luz Agana; Jacques Riby; Jianjun Liu; Hans-Olov Adami; Hatef Darabi; Henrik Hjalgrim; Hui-Qi Low; Keith Humphreys; Mads Melbye; Ellen T Chang; Bengt Glimelius; Wendy Cozen; Scott Davis; Patricia Hartge; Lindsay M Morton; Maryjean Schenk; Sophia S Wang; Bruce Armstrong; Anne Kricker; Sam Milliken; Mark P Purdue; Claire M Vajdic; Peter Boyle; Qing Lan; Shelia H Zahm; Yawei Zhang; Tongzhang Zheng; Nikolaus Becker; Yolanda Benavente; Paolo Boffetta; Paul Brennan; Katja Butterbach; Pierluigi Cocco; Lenka Foretova; Marc Maynadié; Silvia de Sanjosé; Anthony Staines; John J Spinelli; Sara J Achenbach; Timothy G Call; Nicola J Camp; Martha Glenn; Neil E Caporaso; James R Cerhan; Julie M Cunningham; Lynn R Goldin; Curtis A Hanson; Neil E Kay; Mark C Lanasa; Jose F Leis; Gerald E Marti; Kari G Rabe; Laura Z Rassenti; Logan G Spector; Sara S Strom; Celine M Vachon; J Brice Weinberg; Elizabeth A Holly; Stephen Chanock; Martyn T Smith; Paige M Bracci; Christine F Skibola
Journal:  Nat Genet       Date:  2010-07-18       Impact factor: 38.330

10.  Array-based DNA methylation profiling in follicular lymphoma.

Authors:  C O'Riain; D M O'Shea; Y Yang; R Le Dieu; J G Gribben; K Summers; J Yeboah-Afari; L Bhaw-Rosun; C Fleischmann; C A Mein; T Crook; P Smith; G Kelly; A Rosenwald; G Ott; E Campo; L M Rimsza; E B Smeland; W C Chan; N Johnson; R D Gascoyne; S Reimer; R M Braziel; G W Wright; L M Staudt; T A Lister; J Fitzgibbon
Journal:  Leukemia       Date:  2009-07-09       Impact factor: 11.528

View more
  8 in total

1.  Identification of gene-environment interactions in cancer studies using penalization.

Authors:  Jin Liu; Jian Huang; Yawei Zhang; Qing Lan; Nathaniel Rothman; Tongzhang Zheng; Shuangge Ma
Journal:  Genomics       Date:  2013-08-29       Impact factor: 5.736

2.  Racial differences in three major NHL subtypes: descriptive epidemiology.

Authors:  Yang Li; Yu Wang; Zhuoyue Wang; Danhui Yi; Shuangge Ma
Journal:  Cancer Epidemiol       Date:  2015-01-02       Impact factor: 2.984

3.  Four synchronous cancers in a patient with tongue pain as the only symptom.

Authors:  Lene Nyhøj Heidemann; Jørgen Johansen; Stine Rosenkilde Larsen; Jens Ahm Sørensen
Journal:  BMJ Case Rep       Date:  2016-05-05

Review 4.  Risk factors for etiology and prognosis of mantle cell lymphoma.

Authors:  Yu Wang; Shuangge Ma
Journal:  Expert Rev Hematol       Date:  2014-02-22       Impact factor: 2.929

5.  Incidence and mortality trends and geographic patterns of follicular lymphoma in Canada.

Authors:  M Le; F M Ghazawi; A Alakel; E Netchiporouk; E Rahme; A Zubarev; M Powell; L Moreau; O Roshdy; S J Glassman; D Sasseville; G Popradi; I V Litvinov
Journal:  Curr Oncol       Date:  2019-08-01       Impact factor: 3.677

6.  Methylenetetrahydrofolate reductase gene polymorphisms association with the risk of follicular lymphoma: a meta-analysis.

Authors:  Jing-Yan Xu; Yun-Yu Sun; Min Zhou; Jing Wang; Qi-Guo Zhang; Xi-Hui Xu; Hui Zeng; Jian Ouyang
Journal:  Tumour Biol       Date:  2013-01-29

7.  An open-label expanded-access trial of bendamustine in patients with rituximab-refractory indolent non-Hodgkin lymphoma or previously untreated chronic lymphocytic leukemia: BEND-ACT.

Authors:  C T Kouroukis; M Crump; D MacDonald; J F Larouche; D A Stewart; J Johnston; S Sauvageau; E Beausoleil; P Sage; S G Dubois; A Christofides; S Di Clemente; L Sehn
Journal:  Curr Oncol       Date:  2015-08       Impact factor: 3.677

8.  Association between abnormal serum free light chains ratio and known prognostic factors in lymphoma; a nephrology viewpoint.

Authors:  Minoosh Moghimi; Mahshid Kashkooli Behroozi; Mehdi Maghbooli; Sattar Jafari; Saeideh Mazloomzadeh; Aiyoub Pezeshgi
Journal:  J Renal Inj Prev       Date:  2016-12-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.